Skip to content

Physical Activity Through Health Technology in Axial Spondyloarthritis

Expanding Access to Early Exercise Prescriptions for Underserved Patients With Axial Spondyloarthritis: A Digital Health Approach

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07642622
Enrollment
40
Registered
2026-06-11
Start date
2026-06-01
Completion date
2027-06-01
Last updated
2026-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial Spondyloarthritis

Keywords

digital health, exercise, mobile app

Brief summary

The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis (axSpA) to receive exercise recommendations as part of their regular rheumatology care. Researchers want to learn: Whether people with axSpA find the ExerciseRx app easy to use and helpful for supporting regular exercise. Whether using the ExerciseRx app leads to improvements in symptoms, physical function, and disease activity compared with usual care. Participants assigned to the ExerciseRx group will use the app to complete guided exercises for 20-30 minutes, four times per week. They will also receive personalized weekly step-count goals to help increase their physical activity. Researchers will compare outcomes between participants using the app and those receiving usual care.

Interventions

OTHERPhysical activity program intervention

Patients complete home exercise sessions given via the ExerciseRx app over 20-30 minutes 4 times per week for 12 weeks and receive daily step count goals. Patients also receive a FitBit to wear continuously throughout the study, and are given access to view their step counts via the ExerciseRx app, and receive an educational handout with exercises for axial spondyloarthritis.

OTHERUsual Care Group

Patients receive recommendations from their physicians to continue their usual physical activity as tolerated, receive a FitBit to wear continuously throughout the study, with the ExerciseRx app locked to the baseline home screen, and receive an educational handout with exercises for axial spondyloarthritis.

Sponsors

University of Washington
Lead SponsorOTHER
Arthritis Foundation
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of axial spondyloarthritis by a rheumatologist * English speaking * Insufficiently active (less than 150 minutes of moderate intensity aerobic activity per week) * Willing to wear a Fitbit for the study duration * Willing to have or create a Google account and download the Google Health app (previously known as the Fitbit app)

Exclusion criteria

* Currently pregnant * International travel or any circumstance causing lack of access to wi-fi/Internet at any point during the study period * Recent or planned surgery that may affect ability to engage in physical activity * Unable to exercise for health reasons, or a provider has recommended against exercising for safety/health reasons * Unable to walk safely without difficulty, or is a fall risk (i.e., 3+ falls in past 6 months) * History of a fall resulting in a fracture or head injury in the past 6 months * Cardiovascular contraindicators for physical activity, or history of cardiovascular problems that may be exacerbated by physical activity, as defined by their rheumatologist * Diabetes causing hypoglycemia following physical activity

Design outcomes

Primary

MeasureTime frameDescription
Average minutes of physical activity/exercise during the week and % of participants with adherence to 60% or higher of the recommended exercisesWeek 0 (baseline), 6 and 12We will measure feasibility by adherence to the recommended exercises in the intervention arm, including any additional reported physical activity throughout each week. In the usual care arm, participants will report any physical therapy exercises completed from the handout, as well as other physical activity/exercise. Adherence will be measured using the modified Short QUestionnaire to ASsess Health-enhancing physical activity (mSQUASH), a validated tool for capturing physical activity in axSpA. For those in the intervention arm, adherence will also be captured via the built-in tracking features of the ExerciseRx app, providing an additional measure of feasibility. Adherence or engagement with the ExerciseRx app will be measured in three domains: frequency of app use, adherence to recommended exercises, and interaction with behavioral features.
Acceptability of the ExeriseRx app as a platform to complete recommended exercises for axial spondyloarthritis including % of participants with average score above 5 on MAUQ indicating usabilityWeeks 6 and 12We will measure acceptability using the mHealth App Usability Questionnaire (MAUQ). Scores range from 1 to 7 with scores above 5 on a 7-point Likert scale considered to show usability.

Secondary

MeasureTime frameDescription
Change in disease activity over 12 weeksWeeks 0 (baseline), 6, and 12We will measure changes in disease activity over the course of the study with Bath Axial Spondyloarthritis Disease Activity Index (BASDAI), a validated measure in axSpA. BASDAI ranges from 0-10 with 0 indicating remission and 10 indicated very high disease activity.
Change in functional statusWeeks 0 (baseline), 6, and 12We will measure changes in functional status over the course of the study via the Bath Axial Spondyloarthritis Functional Index (BASFI), a validated measure in axSpA. BASFI ranges from 0-10 with 0 indicating full function and 10 indicating severe functional impairment.

Countries

United States

Contacts

CONTACTJoy Chan
joychan@uw.edu206-744-3626
PRINCIPAL_INVESTIGATORRachael Stovall, MD

University of Washington

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 12, 2026